白喉
免疫
医学
破伤风
儿科
不利影响
病毒学
接种疫苗
免疫学
内科学
抗体
作者
M Xie,Xinyu Feng,Hao Sun,Xiong Peng,W Y Zhang,Qi Xu,Min Zhao,Li Zhang
出处
期刊:PubMed
日期:2025-04-06
卷期号:59 (4): 474-477
标识
DOI:10.3760/cma.j.cn112150-20240806-00626
摘要
From July 23, 2018, to December 31, 2019, a total of 299 219 children in Shandong Province received the fifth dose of the diphtheria, tetanus, and acellular pertussis combined vaccine (DTaP). Among these recipients, the distribution by age was as follows: 20 children under 2 years old (0.01%), 273 996 children aged 2 years (91.57%), 20 242 children aged 3 years (6.76%), 3 932 children aged 4 years (1.31%), 963 children aged 5 years (0.32%), and 66 children aged 6 years and above (0.02%). In total, 1 972 cases of adverse events following immunization (AEFI) were reported after the administration of the fifth dose of DTaP, resulting in an incidence rate of 659.05 per 100 000 doses. Among these, 1 718 cases were classified as common vaccine reactions, with an incidence rate of 574.16 per 100 000 doses, while 247 cases were identified as rare reactions, yielding an incidence rate of 82.55 per 100 000 doses. The incidence of AEFIs, as well as the rates of common and rare reactions, exhibited a significant increasing trend with the number of doses administered (all P<0.001). Among the rare reactions, there were 10 cases classified as severe, resulting in a reported incidence of 3.34 per 100 000 doses.
科研通智能强力驱动
Strongly Powered by AbleSci AI